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The t(9; 14)(p13;q32) translocation is associated with ap- 
proximately 50% of lymphoplasmacytoid lymphoma (LPL), 
a subtype of B-cell non-Hodgkin‘s lymphoma (NHL). We 
cloned the chromosomal breakpoint of der (14) from an LPL 
case (1052) and showed that it involved a junction between 
9p13 and the switch y region of the Ig heavy chain locus 
(IgH) on 14q32. Using a VAC contig spanning 1.5 megabase 
(Mb), we determined that the 9p13 breakpoint in one case 
(1052) mapped within a 270-kb restriction fragment con- 
taining two previously reported 9p breakpoints associated 
with a a-heavy chain disease case (MAL) and Ki-1 positive 
diffuse large cell lymphoma (DLCL) cell line (KIS-1). The same 
fragment also contained the PAX-5 gene which encodes a 
B-cell specific transcription factor involved in the control of 
B-cell proliferation and differentiation. The breakpoints of 
KIS-1 and 1052 were mapped within the 5‘ noncoding region 
of PAX-5, while the 9p13 breakpoint of MAL mapped 230 t o  
ONRANDOM CHROMOSOMAL translocations are N typically associated with lymphoid neoplasms where 
they involve a number of protooncogene loci.’ In B-cell non- 
Hodgkin’s lymphoma (NHL), translocations deregulate these 
proto-oncogenes by juxtaposition with regulatory elements 
of genes expressed normally in the cells, most frequently 
immunoglobulin genes (Zg )? Different chromosomal trans- 
locations are associated with specific subtypes of lymphoma, 
and substantial experimental evidence, including studies in 
transgenic mice, indicates that most these oncogenes contrib- 
ute specifically to lymphomagenesis. For instance, 
t(8; 14)(q24;q32), t(8; 22)(q24;ql l), and t(2;8)(p12;q24) 
lead to the deregulated expression of the c-MYC proto-onco- 
gene by juxtaposition to one of the Ig loci in 100% of Bur- 
kitt’s lymph~ma.~  Similarly, rearrangement and deregulation 
of the antiapoptotic gene, BCL-2, caused by t(14;18) 
(q32;q21) has been shown in 70% to 90% of follicular 
lymph0mas.4.~ In approximately 50% of mantle cell lympho- 
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270 kb upstream to  PAX-5. In all three cases, the transloca- 
tion caused the juxtaposition of the PAX-5 gene to  the IgH 
locus in the opposite direction of transcription. When com- 
pared with six other DLCL cell lines lacking t(9; 14)(p13;q32), 
the KIS-1 cell line showed an 11-fold overexpression of PAX- 
5 mRNA and a significantly reduced expression of the p53 
gene, which is normally regulated by PAX-5. Moreover, 
metaphase and interphase fluorescence in situ hybridization 
(FISH) analysis using a VAC clone spanning 1 Mb including 
the PAX-5 as a probe identified chromosomal translocations 
in 5 of 7 cases carrying 9p13 translocations. These findings 
suggest that the PAX-5 gene is the target of the t(9;14) in 
LPL whereby its expression may be deregulated by juxtapo- 
sition to  IgH regulatory elements, thus contributing to 
lymphomagenesis. 
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mas, the t(l1; 14)(q13;q32) results in the overexpression of 
BCL-I (Cyclin DI/PRADI), which regulates cell-cycle pro- 
gression, by juxtaposition with the IgH gene.“’ The BCL- 
6 gene, encoding a POZ-zinc-finger transcription factor, is 
altered by rearrangements or mutations involving its 5’ non- 
coding region in the majority of diffuse large cell lymphomas 
(DLCL) and less frequently in follicular  lymphoma^."^ 
The t(9; 14)(p13;q32) is associated with 50% of lympho- 
plasmacytoid lymphoma (LPL)/immunocytoma (Revised 
European-American Classification of Lymphoid Neoplasms 
[REAL]; small lymphocytic lymphoma with plasmacytoid 
differentiation according to the Working Formulationlo.”). 
This rare type of lymphoma is characterized by the infiltra- 
tion of B cells displaying a lymphoplasmacytoid phenotype, 
the presence of cytoplasmic Ig and serum paraproteins, and 
an indolent clinical course followed by transformation into 
large cell lymphoma.“ LPL are associated with transloca- 
tions involving chromosome 9p13, which are ‘‘promiscu- 
ous” in that various chromosome loci including 14q32, 
lq25, 3q27, 7ql1, 12q13, 12q21, 19~13,  and 9q13 can act 
as reciprocal translocation partners in different cases.” Two 
distinct breakpoint regions linking 9pl1 and 9p13 sequencies 
to the Ig heavy-chain locus (ZgH) on 14q32 have already 
been cloned from a case (MAL) of a-heavy chain disease’’ 
and a Ki-1 positive DLCL cell line (KIS-l),I4 respectively. 
However, the gene on 9p13 involved in these translocations 
has not been identified. 
In further pursuit of the target gene involved in 9p13 
translocation, we analyzed the breakpoint of a typical LPL 
case and compared its genomic location with two previously 
identified cases. This approach led us to identify that the 
translocation breakpoints at 9p13 of all three cases are lo- 
cated within a 270-kb region containing the PAX-S(paired 
homeobox-5) gene.l5.l6 A YAC probe spanning this region 
could also identify chromosomal rearrangements in five out 
of seven (71%) cases with 9p13 translocations by fluores- 
cence in situ hybridization (FISH) analysis. This structural 
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analysis together with the finding of overexpression of the 
PAX-5 mRNA in the IUS-1 cell line suggest that the 
t(9; 14)(p13; q32) translocation deregulates the expression of 
the PAX-5 gene by juxtaposition to the Ig regulatory ele- 
ments. 
MATERIALS AND METHODS 
Tumor biopsies and cell lines. The biopsy (case 1052, 79-year- 
old woman) sample analyzed was derived from a retroperitoneal 
lymph node diagnosed as LPL. Cytogenetic analysis showed that 16 
of 16 metaphases had 46, XX, t(9; 14)(p13;q32). Detailed clinical 
characteristics were previously reported." The KIS-1 cell line de- 
rived from a Ki-l positive DLCL with t(9; 14)(p13;q32) was pre- 
viously des~ribed.'~." The RC-K8 and LY1, 2, 3, 17, 18 cell lines 
were kindly provided by Dr I. Kubonishi (Kouchi Medical College, 
Kouchi, Japan) and Dr H.A. Messner (Ontario Cancer Institute, To- 
ronto, Canada), 
Southem blot analysis was performed as 
described previously.zo A 1.3-kb EcoRI-EcoRI Cp probe and a 6.6- 
kb BamHI-Hind111 JH probe were kindly provided by S.J. Korsmeyer 
(Washington University, St Louis, MO). 
Cloning of chromosomal breakpoints. High-molecular-weight 
DNA from case 1052 was partially digested with Sau3AI and size- 
fractionated by using a low-melting point agarose gel. DNA frag- 
ments ranging from 15 to 23 kb were gel-purified, ligated into the 
A dash I1 vector (Stratagene, La Jolla, CA) and in vitro packaged. 
Recombinant clones, 5 X lo5 were screened by plaque hybridization 
using the Cp  and JH probes. A human placental DNA library pur- 
chased from Stratagene was used for the isolation of 9p13 gennline 
sequences. 
Polymerase chain reaction (PCR) primers, probe preparation, 
and YAC library screening. STS primers (sense 5'-GGAAAT- 
GCCCTCCTACTG-3'; antisense 5'-GACAAGCCAGTAGCT- 
AAG-3') were designed from the 9p13 sequence in the vicinity of 
MAL case's breakp~int. '~ The amplified 153-bp PCR product was 
also used as a probe (MAL). PCR primers (sense 5'-CACAGTGGC- 
AACCTTCAG-3'; antisense 5'-TGAGAGACCTGGCTCTAG-3') 
derived from the 9p13 sequence surrounding the 1052 breakpoint 
were prepared based on the sequence of the 1.5-kb Hind111 fragment, 
which was also used as a probe (1052-1.5H) (Fig 1B). These PCR 
primers were used to screen a human CEPH YAC DNA pools (Re- 
search Genetics, Huntsville, AL). Extraction of YAC DNA was 
performed according to standard techniques." PAX-5 gene probes 
were prepared by reverse transcription (RT)-PCR using primer sets 
to amplify nucleotides 46 to 675 (PAX-5 5 ' :  sense 5'-GTCCATTCC- 
ATCAAGTCC-3'; antisense 5'-GACTCCTGAATACCTTCG-3') 
and 1,721 to 2,370 (PAX-5 3': sense 5'-CATCACCGGACATCT- 
TAG-3'; antisense 5'-CAGAAGTTCTGGCTGTAG-3') of the 
PAX-5 cDNA sequence.15 The pBS8.6BB clone containing pIUS 
probe, where the IUS-1 breakpoint is located, was described pre- 
v i o ~ s l y . ' ~  
FISH. Biotin labeling of YAC DNA, chromosome preparation, 
and FISH were performed as previously described." The signals 
from the YAC were scored in metaphases andor interphases from 
archival fixed suspensions of tumor chromosome preparations. In 
metaphase preparations, the der (9) and the der (14) chromosomes 
were identified and analyzed for the presence of hybridizing signal. 
Presence of the signal on both chromosomes at the breakpoint con- 
firmed rearrangement. In interphase preparation, presence of three 
signals in a significant proportion of cells was considered as evidence 
of the chromosomal translocations involving signals represented by 
the YAC. 
Isolation of YAC end clones and construction of the YAC contig. 
A vectorette-PCR method was used to isolate YAC end probes. 
Southern blot analysis. 
Briefly, 500 ng of each YAC DNA were digested with Rsa I, Dde 
I, and Bfn I and ligated with specific vectorette linkers as described 
by Riley et al?3 First-round PCR was performed using 224 primer 
(5'-CGAATCGTAACCGTTCGTACGAGAATCGCT-3') and YAC 
vector-specific HYACD primer (5'-GGTGATGTCGGCGATATA- 
GGCGCCAGCAAC-3') for the right arm and HYACC primer (5 ' -  
GCTACTTGGAGCCACTATCGACTACGCGAT-3') for the left 
arm. A seminested second-round PCR was performed using 224 
primer and RA-2 primer (5'-TCGAACGCCCGATCTCAAGAT- 
TAC-3') for the right arm and LS-2 primer (5'-TCTCGGTAGCCA- 
AGTTGGWAAGG-3') for the left arm to isolate each YAC end. 
Localization on chromosome 9 of gel-purified each YAC end probe 
was confirmed by hybridization to somatic cell hybrid DNAs con- 
taining human chromosome 9 (NIGMS Human Genetic Mutant Cell 
Repository, Coriell Institute, Camden, NJ). Overlapping between 
YAC clones were evaluated by Southern hybridization. 
Pulsed-field gel electrophoresis (PFGE) analysis. Yeast cells 
were embedded in agarose plugs by a standard method,*' and ana- 
lyzed by PFGE after restriction enzyme digestion using the CHEF 
DR I1 (Bio-Rad, Richmond, CA) as described p rev iou~ ly .~~  The 
insert size of each YAC clone was determined by hybridization with 
total human DNAs to a nondigested plug. Mapping of the YAC 
insert was achieved by partial digestion of the YAC DNA followed 
by hybridization with both YAC end (right and left arms) probes. 
Double digestions were also used for detailed analyses. 
Northern blot analysis and cDNA library screening. Total RNA 
was prepared by the guanidium thiocyanate method and poly(A) 
RNA was selected using Oligotex coated with poly(T) (Qiagen, 
Chatsworth, CA). Northern blot analyses were performed as de- 
scribed previously." l X lo6 plaques from a cDNA library con- 
structed from the BJAB cell line were screened with the PAX-5 5' 
cDNA probe. 
DNA sequencing was performed by the di- 
deoxy chain termination method using an automated sequencing 
system, AB1 473A (Applied Biosystems, Foster City, CA). 
DNA sequencing. 
RESULTS 
Molecular cloning of the t(9; 14) breakpoint region in an 
LPL case. Southern blot analysis of BamHI-digested DNA 
from case 1052 using the Cp probe showed two rearranged 
bands (Fig 1A). One of these bands (8.0 kb) did not comi- 
grate with the JH band in the BamHI digest, suggesting the 
existence of a chromosomal breakpoint between the JH and 
Cp loci of the ZgH gene. To clone this fragment, a genomic 
library was constructed and screened with both Cp and JH 
probes. As a result, we isolated a clone (A4) containing the 
IgH Sp region juxtaposed to an unknown fragment (Fig 
l e ) .  FISH analysis showed that clone A4 hybridized to both 
14q32 and 9p13 chromosomal loci on normal metaphase 
spreads (data not shown), indicating that it represented the 
breakpoint region of the der (14) chromosome. Localization 
to chromosome 9 was also confirmed by hybridization to a 
somatic cell hybrid panel with the 1052-1.5H probe (data 
not shown). 
Three NHL-associated 4 1 3  breakpoints map within a 
270-kbgenomicregioncontainingthePAX-5 locus. Restric- 
tion mapping of clone A4 showed that the sequences in- 
volved in the breakpoints of case 1052 and those previously 
reported in MAL and IUS-1 were independent from each 
other. To investigate the genomic distance between these 
three breakpoints, we isolated YAC clones spanning this 
region. For this purpose, we designed STS primers in the 
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vicinity of each breakpoint, and screened a CEPH YAC 
library. Overlapping YAC clones spanning 1.5 Mb were 
isolated and mapped to the 9p13 locus by FISH analysis 
(Fig 2, FISH data not shown). A representative YAC contig 
(Fig 2) was constructed based on the overlapping hybridiza- 
tion pattem given by YAC end probes. Using mapping by 
PFGE, we found that the three breakpoints were located 
within 270 kb which also contained the PAX-5 gene, recently 
assigned to the. 9p13 locus.2s In addition, two of the 
breakpoints (case 1052 and KIS-1) mapped within the same 
150-kb Nru YNot I fragment (Fig 3), while the breakpoint 
of case MAL mapped 230 to 270 kb upstream to the PAX- 
5 locus. 
Relationship between 9pl3 breakpoints and the PAX-5 
gene. To precisely determine the genomic distance be- 
tween the breakpoints and PAX-5 gene sequences, we iso- 
27ah 
CEpHlMQ L O  OR I.lWkh 
L O  /-on i .nah CEPH9SlW YACa 
L O R  8Y*b 
Fig 2. Mapping of three 9p13 breakpoints and P A X 4  gene within 
270 kb on YAC contig. Three representative Mega Yac clones span- 
ning the three breakpoints and PAX-5 gene are shown. Open circles 
at the termini of YACs indicate nonchimeric ends confirmed by hy- 
bridization to  somatic cell hybrid DNA with vectorette-PCR products. 
Insert sizes were determined by PFGE and the orientation of both 
the right (R) and left (L) YAC arms are shown. Each arrow indicates 
the breakpoint locus involved in t(9;141(p13;q32). N, Not I; Nr, Nru 1. 
Fig 1. Molecular cloning of the breakpoint of case 
1052 carrying t(9; 14)(p13;q32) translocation. (A) 
Southern blot analysis of case 1052 DNA with Cp 
and JH probes. Ten micrograms of high-molecular- 
weight DNA was digested with B a M l ,  electropho- 
resed on a 0.8% agarose gel, and blotted. The filter 
was sequentially hybridized with Cp and JH probes. 
The Cp probe detected two rearranged bands of 14.0 
kb and 8.0 kb. The 14.0-kb band comigrated with the 
JH rearranged band, suggesting it to  be a productive 
rearrangement (shown by dashed line), whereas the 
8.0-kb band does not show any comigration, sug- 
gesting that it may represent the derivative 14 chro- 
mosome (shown by an arrow). Size markers of A I  
Hindlll are shown on the left. (E) Restriction map of 
clone A4 representing derivative 14 chromosome is 
shown, together with the germline map of the IgH 
locus at 14q32. The arrow indicates the chromo- 
somal breakpoint. B, BamHI; H, Hindlll; E, €CON 
lated the 5' region of this gene by screening a cDNA library 
derived from the BJAB cell line. Two kinds of PAX-5 cDNA 
clones were isolated, which differed in their 5' termini. One 
of the cDNA species was identical to that previously reported 
for PAX-5.'' The other cDNA species, represented by phage 
XBJ-I I ,  contained a different 5' cDNA sequence (Fig 4A). 
Nucleotide sequencing showed that this clone contained a 
putative alternative in-frame translation initiation site 
(ATG), partly corresponding to Kozak's consensus se- 
quence" (Fig 4B). The N-terminal sequences of the protein 
putatively encoded by this cDNA species differ from those 
previously reported for PAX-5, although the main functional 
domains of the protein remain conserved. Consistent with 
these two cDNA species, Northern analysis showed two al- 
ternatively spliced transcripts of I O  kb and 10.5 kb, using a 
PAX-5 probe derived from the 3' end (Fig 4C). On the other 
hand, the IO-kb and 10.5-kb transcripts were specifically 
detected by the pKIS and 1.7B genomic probes, respectively, 
suggesting that the 5' region of PAX-5 contains two altema- 
tively used first exons ( l a  and lb  in Fig 4D). Most B-cell 
lines (eg, RC-K8 and KIS-I) express both the IO-kb and the 
10.5-kb transcripts, which use the first (ATGI) and second 
translation initiation site (ATG2). respectively. Only the 10- 
kb transcript is detectable in the RAMOS cell line by North- 
em analysis, although the 10.5-kb mRNA species was also 
identified by RT-PCR analysis (data not shown). 
The breakpints of KIS-I and case 1052 mapped 2.5 kb 
upstream to the ATGI site and just 5' to the ATG2 site within 
exon I b (Fig 4B and D). In both cases, the PAX-5 gene was 
juxtaposed to the IgH locus in the opposite direction to tran- 
scription as a result of the ((9; 14) translocation. In case 1052, 
((9; 14) removed the enhancer p (Ep) element and the ATGl 
site of PAX-5, while in the case of the IUS-I cell line, the Ep 
sequences and both PAX-5 exon 1 s remain on der (14). 
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Fig 3. PFGE analysis of the CEPH 788C3. YAC 
completion with Not 1, Nru 1, and Not IINru 1, and 
analyzed by PFGE. The same blot was hybridized 
sequentially with the probes indicated. Comigration 
of bands after hybridization with the probes is indi- 
cated by dashed lines. The size of the molecular- 
weight marker is shown on the left in kilobases. probe: MAL pKlS 1052-1 .SH 
plugs prepared from CEPH 788C3 were digested to 
The PAX-5 gene is overexpressed in a cell line carrying 
t(9; 14). To determine whether the juxtaposition to IgH had 
any effect on PAX-5 gene expression, we compared PAX-5 
RNA levels in KIS-I and other DLCL cell lines sharing the 
same histological subtype, but lacking t(9; 14)(p13;q32) (Fig 
5). Densitometric analysis of the hybridization bands showed 
an 1 I-fold overexpression in the KIS-I cell line when com- 
pared with the mean value of the other six cell lines. 
The p53 gene, which is negatively regulated by PAX-5, 
is downregulated in an NHL cell line containing t(9; 14) and 
overexpressing PAX-5. The expression of the p53 gene is 
physiologically modulated by PAX-5.*' Because the KIS- 1 
cell line overexpresses PAX-5, we examined whether this 
was associated with p53 downregulation by analyzing p53 
RNA levels in KIS-I cells versus 6 control NHL lines. The 
results showed that p53 RNA expression is significantly re- 
pressed in KIS-I cells (Fig 5) .  
Frequent detection of 9p13 breakpoint in LPL by FISH 
analysis. To investigate the frequency of the PAX-5 gene 
involvement in B-cell NHL, we analyzed 20 LPL cases, 
including 2 cases with t(9; 14) and a panel of 50 lymphoma 
cases representative of the main NHL subtypes by Southern 
blot analyses using the MAL, pKIS, and 1.7B probes. How- 
ever, we did not detect any rearrangement (data not shown), 
suggesting that none of the probes used was representative 
of a rearrangement cluster. We then decided to use the 
CEPH788C3 YAC DNA as a probe for metaphase and/or 
interphase FISH analysis to examine a larger genomic region 
spanning the PAX-5 gene. Seven B-cell NHL cases, includ- 
ing 3 LPL and 2 DLCL cases with t(9; 14)(p13;q32) and 2 
DLCL cases with other translocations involving 9p13 (Table 
1) were selected for this analysis. The results show that 3 
LPL and a DLCL case carrying 
. -  
P A X 4  S P A X 4  3' 
t(9;14), together with 1 
DLCL case with a t(3;9)(q27;p13) show rearrangements of 
9p13 within the genomic region represented by the YAC 
clone (Table I ,  Fig 6). 
DISCUSSION 
The t(9; 14)(pl3;q32) translocation is a recurrent chromo- 
somal abnormality associated with a significant fraction of 
LPL cases and less frequently with other NHL subtypes.'" 
Our results identify a chromosomal subregion at 9p13 which 
is involved in this translocation in most cases of LPL and 
provides evidence in a few cases that the chromosomal 
breakpoints directly involve the PAX-5 gene. These results 
have implications for the consequences of t(9; 14)(p13;q32) 
on PAX-5 expression, for the role of PAX-5 in lymphoma- 
genesis, and for the possible diagnostic use of 9p13 
breakpoints in NHL diagnosis. 
Consequences of t(9; 14)(p13;q32) on PAX-5 gene ex- 
pression. Our results show that 9p13 chromosomal 
breakpoints are located within a 270-kb genomic region 
which contains the PAX-5 gene in three cases. In addition, 
the fact that the 9p13 breakpoints were detected by the 1- 
Mb YAC containing the PAX-5 gene in 6 of 8 NHL cases 
by FISH analysis indicates that the breakpoints may be in 
relative proximity to the PAX-5 gene in most LPL and DLCL 
cases. In analogy to the chromosomal translocations involv- 
ing the IgH locus and the BCL-I, BCL-2, or c-MYC loci in 
other types of NHL,?'.'" it is conceivable that at these dis- 
tances IgH gene regulatory elements such as IgH transcrip- 
tional enhancers and locus control regions-" may deregulate 
PAX-5 expression. This model is directly supported by the 
findings in case KIS-I and case 1052, where the IgH locus 
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Fig 4. Alternative translation initiation sites of the PAX-5 gene and the detailed location of the chromosomal breakpoints. (A) Two kinds 
of PAX-5 cDNA structure. Comparison of the AW-11 clone containing a putative alternative translation initiation site (ATG2I t o  that previously 
reported in PAX-5 cDNA which contained the ATGl site only. Coding regions are boxed. Black boxes, bright and dark gray dotted boxes 
represent paired domains, serinelthreonine rich domains, and serine/threonine/proline rich domains. Untranslated 5' and 3' regions (UTI are 
indicated. B, BamHI; K, Kpn I; P, Pst 1. (B) Partial cDNA sequence of the ABJ-11 clone containing ATG2 and the deduced amino acid sequence. 
Two possible translation initiation sites of this clone are boxed and the preceding in-frame stop codon is underlined. Case 1052's breakpoint 
is indicated by the arrow. (CI Alternative usage of exon 1 gives rise to  two different sized transcripts of 10.0 and 10.5 kb in the B-cell lineage. 
Northern analysis of the three B-cell lines using three different PAX-5 probes. 2.5 pg  poly(A) RNA from RAMOS and RC-K8 cell lines and 1.0 
p g  poly(A) RNA from KIS-1 cell line were loaded. The filter was sequentially hybridized with 3' PAX-5 cDNA probe and two genomic probes 
containing exon l a  (pKIS) and l b  (1.781. respectively. Both the PAX-5 3' and the 1.78 probes cross-hybridize to  remnant 28s ribosomal RNA. 
RAMOS, Burkitt's lymphoma cell line; RC-K8, DLCL cell line; KIS-1, Ki-1 positive DLCL cell line with t(9;14). (DI Genomic structure of the 5' 
region of the PAX-5 gene and the location of breakpoints of KIS-1 and case 1052 are indicated. Nucleotide numbers shown above each exon 
are the same as in the PAX-5 cDNA sequence reported by Adams et al." Open and closed boxes indicate noncoding and coding regions of 
PAX-5, respectively. ATGl in exon l a  and ATGZ in exon l b  are shown by horizontal arrows. Alternative splicing generates 10.5-kb and 10.0- 
kb transcripts as shown below the mao. The vertical anows indicate the chromosomal breakpoints of KIS-1 and case 1052. B, EamHI; Sc, 
Sadl; E, EcoRI; H, Hidlll; SI, Sal 1. 
is directly juxtaposed to the PAX-5 gene in the opposite 
direction of transcription, and by the striking overexpression 
of the PAX-5 mRNA in the KIS-I cell line. In addition, the 
observation that the 9 p l 3  locus seems to be disrupted also 
in reciprocal translocations involving partner chromosomes 
other than 14q32 (see case 1615 in Table I )  suggests that 
multiple chromosomal regions may contribute to PAX-5 de- 
regulation perhaps by juxtaposing different regulatory ele- 
ments, a mechanism analogous to that observed for chromo- 
somal translocations involving the BCL-6 gene in DLCL.* 
The PAX gene fam- 
ily include a number of transcription factors which share 
homologous DNA binding and dimerization domains, desig- 
Role of PAX-5 in l~mnpliorna~eriesis. 
nated as paired domains, and are characterized by a highly 
conserved a-helical structure at the N Through 
transcriptional regulation of downstream genes, PAX genes 
control embryonal development and organogenesis. In addi- 
tion, various PAX genes have been implicated in oncogene- 
s k J 4  The PAX-3 and PAX-7 genes have been shown to fuse 
to fork head domain gene (FKHR) by t(2: 13)(q35:q14) and 
t( 1 : 13)(p36;q 14) translocations in alveolar rhabdomyosar- 
The PAX-2 and PAX-5 genes have been found coma.3s.36 
highly expressed in Wilms' tumor," and in brain tumors 
such as medulloblastoma and glioblastoma,3x respectively. 
although the mechanism responsible for their altered expres- 
sion has not been identified. 
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BL DLCL 
n t  1 
Fig 5. PAX-5 mRNA is overexpressed in KIS-1 cell 
line carrying tl9;14). A 10-pg aliquot of total RNA 
was loaded onto each lane, blotted, and hybridized 
with PAX-5 3' and p53 cDNA probes, together with 
GAPDH probe to control for the amount of RNA. All 
the cell lines except for HELA, which acted as the 
negative control for PAX-5 expression, are of B-cell 
lineage. Histological subtype of the original patients' 
sample are indicated on the top. BL, Burkin's 
lymphoma; DLCL, diffuse large cell lymphoma. 
10.0 kb - 
PA X-5 
. ... 
GAPDH 
Case No. 
1052 
1113 
1178 
1800 
96080706 
1615 
1068 
Histology 
LPL 
LPL 
LPL 
DLCL 
DLCL 
DLCL 
DLCL 
9p13 
Aberration 
t(9: 14)(p13:q32) 
t(9: 14)(p13;q32) 
t(9; 14)(p13;q32) 
t(9: 14Mp13;q32) 
t(9: 14)(p13:q32) 
t(3:9)(q27;P13) 
t(7:9)(q32:p13) 
P53 
The PAX-5 gene was cloned as a human homolog of the 
sea urchin TSAP (tissue-specific activator protein), and 
turned out to be the gene encoding 50-kD BSAP (B-cell 
lineage specific activator protein)." PAX-5 is expressed in 
fetal brain and liver during the embryonic period and, after 
birth, is exclusively expressed in B lymphocytes and testis. 
Several observations suggest that PAX-5 plays a significant 
role in the control of B-cell proliferation and differentiation. 
Its loss of function results in a maturation arrest at the pro- 
B cell stage39 and its overexpression results in proliferation 
of splenic B cells.40 On the other hand, treatment with anti- 
sense oligonucleotides strikingly reduces lipopolysaccha- 
ride-induced proliferation of splenic B cells and spontaneous 
proliferation of B-lymphoma cell lines?" Furthermore, PAX- 
5 gene expression is upregulated by the product of the E2A 
proto-oncogene,'" whereas PAX-5 itself downregulates the 
Table 1. Rearrangement of YAClCEPH788C3) Signal in Tumors 
Wkh 9p13 Chromosomal Translocations 
YAC Status 
MetaDhase InterDhase 
Rearranged Rearranged 
Rearranged Rearranged 
NT Rearranged 
NT Not rearranged 
Rearranged Rearranged 
NT Rearranged 
NT Not rearranged 
Abbreviation: NT, not tested. 
expression of ~53." Taken together, these observations sug- 
gest that PAX-5 is crucial in the control of proliferation 
of mature B cells and that its deregulated expression may 
contribute to abnormal proliferation and thus to lymphoma- 
genesis. 
In this study we have also identified alternative transcripts 
and translation initiation sites that had not been previously 
reported for the PAX-5 gene. Interestingly, the amino acid 
sequence (MEIHCKHDPFASMH) encoded by the novel 
exon Ib identified in this study is 92% homologous to that 
(MDMHCKADPFSAMH) encoded by exon 1 of the PAX- 
2 gene," suggesting that this domain may have functional 
significance. Alternatively spliced mRNAs encoding differ- 
ent open reading frames are found in the same (class 111) 
PAX family genes including P A X 2  and PAX-8,42"3 and in 
the PAX-8 gene such alternative forms are developmentally 
regulated and generate isoforms with different transactiva- 
tion properties. These observations suggest that the two 
PAX-5 mRNAs (10.0 kb and 10.5 kb) which are expressed in 
most B-cell lines may encode functionally distinct proteins, 
whose role in normal B-cell development and possibly 
lymphomagenesis requires further investigation. 
Alterations of the PAX-5 gene 
represent the first molecular lesion found in association with 
LPL. However, the low frequency of this rearrangement de- 
tected by conventional Southern analysis suggests the possi- 
bility that the breakpoints at 9p13 may be dispersed within 
a several-hundred kilobase range or the existence of multiple 
breakpoint cluster regions. Metaphase andor interphase 
FISH analysis of NHL samples using the 1-Mb CEPH788C3 
YAC spanning the PAX-5 gene as a probe may complement 
Diagnostic implications. 
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Fig 6. Rearrangement of nonchimeric YACICEPH 788C3) in lymphomas with 9p13 chromosomal translocations. I1 through 4) Case 1113. l1 
and 2) A partial metaphase of a tumor cell showing hybridization signals at  the breakpoints of der (9)  end der (14) chromosomes (arrowheads). 
(1) and the corresponding  DAPl image showing a G-banding like staining of chromosomes (2). l3 and 4) Interphase nuclei from the same case 
showing two signals in a normal nucleus 13) and three signals in a tumor nucleus (4). 15 and 6) Interphase nuclei from case 1052 showing two 
signals in a normal nucleus (5) and three signals in a tumor nucleus (6). Positive signals in interphase FISH analysis are indicated by arrows. 
or  substitute conventional  cytogenetic  analysis  for  detecting 
these  chromosomal  abnormalities. In addition,  this  approach 
may facilitate the detection of cytogenetically  undetectable 
9pl3 rearrangements. Finally, 9p 13 rearrangements, which 
are  common  in  LPL,  but occasionally present  in  DLCL,  may 
represent useful  clonal markers  to  determine  whether some 
LPL cases can  progress into DLCL. 
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